PACLITAXEL

NDC 67457-937 · Mylan Institutional LLC

Generic namePACLITAXEL

Dosage formINJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION

RouteINTRAVENOUS

Active ingredient(s)PACLITAXEL

Strength100 mg/20mL

Pharmacologic classMicrotubule Inhibition [PE], Microtubule Inhibitor [EPC]

Marketing categoryANDA

Packages

67457-937-50 — 20 mL in 1 VIAL (67457-937-50)

J9264 — Injection, paclitaxel protein-bound particles, 1 mg Medicare Part B payment limit (ASP + 6%): $6.59

FDA lists these products with the same active ingredient.

25021-255 — Paclitaxel, 46708-620 — Paclitaxel, 46708-621 — Paclitaxel, 46708-622 — Paclitaxel, 61703-015 — PACLITAXEL, 61703-342 — PACLITAXEL, 62332-620 — Paclitaxel, 62332-621 — Paclitaxel, 62332-622 — Paclitaxel, 63323-763 — Paclitaxel, 68001-516 — Paclitaxel, 68001-651 — Paclitaxel, 68001-705 — Paclitaxel, 68083-178 — paclitaxel, 68083-179 — paclitaxel, 68083-180 — paclitaxel, 68817-134 — Paclitaxel, 69097-398 — Paclitaxel protein-bound particles, 69339-227 — Paclitaxel, 69339-228 — Paclitaxel, +20 more

From the FDA National Drug Code Directory, retrieved 2026-08-24. Product listings are submitted by labelers; FDA does not verify them.